BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 21347606)

  • 1. Vasopressors and inotropes in the treatment of human septic shock: effect on innate immunity?
    Hartemink KJ; Groeneveld AB
    Inflammation; 2012 Feb; 35(1):206-13. PubMed ID: 21347606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The hemodynamics of human septic shock relate to circulating innate immunity factors.
    Hartemink KJ; Groeneveld AB
    Immunol Invest; 2010; 39(8):849-62. PubMed ID: 20718660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vasopressors and Inotropes in Sepsis.
    Stratton L; Berlin DA; Arbo JE
    Emerg Med Clin North Am; 2017 Feb; 35(1):75-91. PubMed ID: 27908339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of vasoactive drugs on mortality in patients with severe sepsis and septic shock. A network meta-analysis of randomized trials.
    Belletti A; Benedetto U; Biondi-Zoccai G; Leggieri C; Silvani P; Angelini GD; Zangrillo A; Landoni G
    J Crit Care; 2017 Feb; 37():91-98. PubMed ID: 27660923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stress doses of hydrocortisone reverse hyperdynamic septic shock: a prospective, randomized, double-blind, single-center study.
    Briegel J; Forst H; Haller M; Schelling G; Kilger E; Kuprat G; Hemmer B; Hummel T; Lenhart A; Heyduck M; Stoll C; Peter K
    Crit Care Med; 1999 Apr; 27(4):723-32. PubMed ID: 10321661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mortality benefit of vasopressor and inotropic agents in septic shock: a Bayesian network meta-analysis of randomized controlled trials.
    Oba Y; Lone NA
    J Crit Care; 2014 Oct; 29(5):706-10. PubMed ID: 24857641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Norepinephrine vs. dopamine: new recommendations for initial vasopressor selection in septic shock.
    Bartel B
    S D Med; 2014 May; 67(5):200-1. PubMed ID: 24851468
    [No Abstract]   [Full Text] [Related]  

  • 8. Diastolic arterial blood pressure: a reliable early predictor of survival in human septic shock.
    Benchekroune S; Karpati PC; Berton C; Nathan C; Mateo J; Chaara M; Riché F; Laisné MJ; Payen D; Mebazaa A
    J Trauma; 2008 May; 64(5):1188-95. PubMed ID: 18469640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Days alive and free as an alternative to a mortality outcome in pivotal vasopressor and septic shock trials.
    Russell JA; Lee T; Singer J; De Backer D; Annane D
    J Crit Care; 2018 Oct; 47():333-337. PubMed ID: 29958734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating endothelin and nitrate-nitrite relate to hemodynamic and metabolic variables in human septic shock.
    Groeneveld AB; Hartemink KJ; de Groot MC; Visser J; Thijs LG
    Shock; 1999 Mar; 11(3):160-6. PubMed ID: 10188767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemodynamic support in fluid-refractory pediatric septic shock.
    Ceneviva G; Paschall JA; Maffei F; Carcillo JA
    Pediatrics; 1998 Aug; 102(2):e19. PubMed ID: 9685464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adrenergic support in septic shock: a critical review.
    Póvoa P; Carneiro AH
    Hosp Pract (1995); 2010 Feb; 38(1):62-73. PubMed ID: 20469626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacotherapy update on the use of vasopressors and inotropes in the intensive care unit.
    Jentzer JC; Coons JC; Link CB; Schmidhofer M
    J Cardiovasc Pharmacol Ther; 2015 May; 20(3):249-60. PubMed ID: 25432872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vasoactive drug support in septic shock.
    Dries DJ
    Shock; 2006 Nov; 26(5):529-30. PubMed ID: 17047528
    [No Abstract]   [Full Text] [Related]  

  • 15. Recommendations for the treatment of patients with septic shock.
    Meier-Hellmann A; Reinhart K
    Acta Anaesthesiol Scand Suppl; 1997; 111():177-80. PubMed ID: 9421002
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of norepinephrine on the outcome of septic shock.
    Martin C; Viviand X; Leone M; Thirion X
    Crit Care Med; 2000 Aug; 28(8):2758-65. PubMed ID: 10966247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enoximone in contrast to dobutamine improves hepatosplanchnic function in fluid-optimized septic shock patients.
    Kern H; Schröder T; Kaulfuss M; Martin M; Kox WJ; Spies CD
    Crit Care Med; 2001 Aug; 29(8):1519-25. PubMed ID: 11505119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of vasoactive drugs on intestinal functional capillary density in endotoxemic rats: intravital video-microscopy analysis.
    Nacul FE; Guia IL; Lessa MA; Tibiriçá E
    Anesth Analg; 2010 Feb; 110(2):547-54. PubMed ID: 20081137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noradrenaline as a vasoactive agent in septic shock.
    Tordoff SG; Thompson JL; Williams AW
    Intensive Care Med; 2000 May; 26(5):648. PubMed ID: 10923747
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of stress doses of hydrocortisone on S-100B vs. interleukin-8 and polymorphonuclear elastase levels in human septic shock.
    Mussack T; Briegel J; Schelling G; Biberthaler P; Jochum M
    Clin Chem Lab Med; 2005; 43(3):259-68. PubMed ID: 15843228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.